$0.34
(7.64%)
Add to watchlist
Create an alert
Stocks and Shares ISAOrchestra BioMed Holdings, Inc. is a biomedical innovation company. The Company’s lead product candidates include Atrioventricular Interval Modulation (AVIM) therapy for the treatment of hypertension (HTN), the leading risk factor for death worldwide and the Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the leading cause of mortality worldwide. The Company develops bioelectronic therapies based on patented Cardiac Neuromodulation Therapy (CNT) technology. The AVIM is a bioelectronic therapy candidate designed to substantially and persistently lower blood pressure. Its Virtue SAB is a proprietary drug/device combination product candidate for the treatment of artery disease that is designed to deliver a proprietary, investigational, extended-release formulation of sirolimus (SirolimusEFR) to the vessel wall during balloon angioplasty without the need for balloon coating or a permanent implant.
Company Information
About this company
Key people
David P. Hochman
Chairman of the Board, Chief Executive Officer
Darren R. Sherman
President, Chief Operating Officer, Director
Andrew Lawrence Taylor
Chief Financial Officer
Eric S. Fain
Lead Independent Director
Jason M. Aryeh
Independent Director
Christopher Cleary
Independent Director
Pamela Ann Connealy
Independent Director
John Mack
Independent Director
Click to see more
Key facts
- Shares in issue56.46m
- EPICOBIO
- ISINUS68572M1062
- LocationUnited States
- SectorHealthcare
- IndustryMedical Equipment & Supplies
- Market cap$251.27m
- Employees70
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.